Pierre Fabre Overview

  • Founded
  • 1951
  • Status
  • Private
  • Employees
  • 10,500
  • Latest Deal Type
  • Debt
  • Latest Deal Amount
  • $138M
Latest Deal Amount

Pierre Fabre General Information


Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medical innovation. The company's services are offered through an innovation laboratory that promotes research and development in pharmaceuticals, cosmetics and biotechnological domains so as to develop new drugs and health-friendly products without using chemicals and toxic ingredients, enabling medical researchers to recommend and develop all natural healthcare products abiding by the legal compliance and governmental regulations.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Primary Office
  • 12, Avenue Hoche
  • 75008 Paris
  • France
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pierre Fabre Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Debt - General 18-Nov-2011 $138M 00000 Completed Profitable
To view Pierre Fabre’s complete valuation and funding history, request access »

Pierre Fabre Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Owner and operator of pharmaceutical and cosmetics company intended to assist in research and development through medica
Paris, France
10,500 As of 2020
000000000 00000

000000 0

re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
Montreal, Canada
000 As of 0000


veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
London, United Kingdom
00 000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pierre Fabre Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Knight Therapeutics Corporation Montreal, Canada 000 000000000
0000000 Private Equity-Backed London, United Kingdom 00 000000
000000 00000 Corporation Mumbai, India 0000
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000000 000.00
0000000 0000000 Corporation Dublin, Ireland 00000 000000&0
You’re viewing 5 of 12 competitors. Get the full list »

Pierre Fabre Executive Team (7)

Name Title Board Seat Contact Info
Frederic Duchesne President & Chief Executive Officer of pharmaceuticals division
Eric Ducournau Chief Executive Officer
Laurent Fredon Head of External Innovation in Consumer Healthcare
Eric Gouy Senior Vice President of Finance
Clément Rattier Analyst, Corporate Licensing and Acquisitions
You’re viewing 5 of 7 executive team members. Get the full list »

Pierre Fabre Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pierre Fabre Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 24-May-2017 000000000 00000 00 Biotechnology
000000 0000000 31-Jan-2017 000000000000000000 Medical Records Systems
Youboox 28-Apr-2015 Early Stage VC 00000 Publishing
To view Pierre Fabre’s complete investments history, request access »